|
|
Volumn 879, Issue 25, 2011, Pages 2673-2676
|
|
Validation of a method for the determination of the anticancer agent Combretastatin A1 phosphate (CA1P, OXi4503) in human plasma by HPLC with post-column photolysis and fluorescence detection
a
|
|
Author keywords
CA1P; Fluorescence; HPLC; Ion pairing; OXi4503; Plasma
|
|
Indexed keywords
ANTI-CANCER AGENTS;
BISPHOSPHATES;
CA1P;
FLUORESCENCE DETECTION;
HPLC;
HUMAN PLASMAS;
HYDROGEN SULPHATE;
INJECTION VOLUME;
INTRA-ASSAY PRECISION;
ION-PAIRING;
ION-PAIRING AGENTS;
OXI4503;
POST-COLUMN;
PRODRUGS;
REVALIDATION;
TETRABUTYLAMMONIUM;
VALIDATED METHODS;
VASCULAR DISRUPTING AGENTS;
FLUORESCENCE;
PHOTOLYSIS;
PLASMA (HUMAN);
PLASMAS;
ANTINEOPLASTIC AGENT;
COMBRETASTATIN A1 PHOSPHATE;
TETRABUTYLAMMONIUM;
ACCURACY;
ARTICLE;
BLOOD LEVEL;
DRUG STRUCTURE;
FLUORESCENCE;
HIGH PERFORMANCE LIQUID CHROMATOGRAPHY;
HUMAN;
ION PAIR CHROMATOGRAPHY;
LIMIT OF QUANTITATION;
PHOTOLYSIS;
PLASMA;
PRIORITY JOURNAL;
SEPARATION TECHNIQUE;
VALIDATION STUDY;
ANIMALS;
ANTINEOPLASTIC AGENTS;
CHROMATOGRAPHY, HIGH PRESSURE LIQUID;
DIPHOSPHATES;
HUMANS;
LINEAR MODELS;
MICE;
REPRODUCIBILITY OF RESULTS;
SENSITIVITY AND SPECIFICITY;
SPECTROMETRY, FLUORESCENCE;
STILBENES;
|
|
EID: 84860390417
PISSN: 15700232
EISSN: 1873376X
Source Type: Journal
DOI: 10.1016/j.jchromb.2011.07.014 Document Type: Article |
|
Times cited : (5)
|
|
References (9)
|
